The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus
Authors
Keywords
Heart failure, cGMP, Pressure–volume relationship, sGC activator, Diabetic complications, Insulin dependent diabetes mellitus, Oxidative stress, PDE-5, Apoptosis, Fibrosis
Journal
Cardiovascular Diabetology
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-10-31
DOI
10.1186/s12933-015-0309-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signalling
- (2014) Christian Beyer et al. ANNALS OF THE RHEUMATIC DISEASES
- Molecular mechanisms of diabetic cardiomyopathy
- (2014) Heiko Bugger et al. DIABETOLOGIA
- Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways
- (2014) Karina Huynh et al. PHARMACOLOGY & THERAPEUTICS
- Turning on cGMP-dependent pathways to treat cardiac dysfunctions: boom, bust, and beyond
- (2014) Robert Lukowski et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Rat model of exercise-induced cardiac hypertrophy: hemodynamic characterization using left ventricular pressure-volume analysis
- (2013) Tamás Radovits et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Acute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculation
- (2013) James T Pearson et al. Cardiovascular Diabetology
- Preserved endothelium-dependent dilatation of the coronary microvasculature at the early phase of diabetes mellitus despite the increased oxidative stress and depressed cardiac mechanical function ex vivo
- (2013) Evangelia Mourmoura et al. Cardiovascular Diabetology
- Vascular dysfunction induced by hypochlorite is improved by the selective phosphodiesterase-5-inhibitor vardenafil
- (2013) Tamás Radovits et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress and protects against myocardial ischemia/reperfusion injury in type 2 diabetic mice
- (2013) Saisudha Koka et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide
- (2012) Fadi N. Salloum et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure†
- (2012) Erland Erdmann et al. EUROPEAN HEART JOURNAL
- Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes
- (2012) Mihai Gheorghiade et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cinaciguat prevents neointima formation after arterial injury by decreasing vascular smooth muscle cell migration and proliferation
- (2012) K. Hirschberg et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Nitric Oxide- and Heme-Independent Activation of Soluble Guanylate Cyclase Attenuates Peroxynitrite-Induced Endothelial Dysfunction in Rat Aorta
- (2012) Sevil Korkmaz et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Cyclic Guanosine Monophosphate Signaling and Phosphodiesterase-5 Inhibitors in Cardioprotection
- (2012) Rakesh C. Kukreja et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3′,5′ guanosine monophosphate (cGMP) level in podocytes
- (2012) Lilla Fang et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The Soluble Guanylyl Cyclase Activator Bay 58-2667 Selectively Limits Cardiomyocyte Hypertrophy
- (2012) Jennifer C. Irvine et al. PLoS One
- Pre-conditioning with the soluble guanylate cyclase activator Cinaciguat reduces ischaemia–reperfusion injury after cardiopulmonary bypass
- (2010) Tamás Radovits et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Comparative investigation of the left ventricular pressure-volume relationship in rat models of type 1 and type 2 diabetes mellitus
- (2009) Tamás Radovits et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- The phosphodiesterase-5 inhibitor vardenafil improves cardiovascular dysfunction in experimental diabetes mellitus
- (2009) T Radovits et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacological Activation of Soluble Guanylate Cyclase Protects the Heart Against Ischemic Injury
- (2009) Sevil Korkmaz et al. CIRCULATION
- Cinaciguat (BAY 58–2667) Improves Cardiopulmonary Hemodynamics in Patients With Acute Decompensated Heart Failure
- (2009) Harald Lapp et al. CIRCULATION
- Vardenafil protects against myocardial and endothelial injuries after cardiopulmonary bypass☆
- (2009) Gábor Szabó et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Selective phosphodiesterase-5 inhibition reduces neointimal hyperplasia in rat carotid arteries after surgical endarterectomy
- (2009) Kristóf Hirschberg et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy
- (2008) Sophie Linthout et al. BASIC RESEARCH IN CARDIOLOGY
- Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of the Soluble Guanylate Cyclase Activator Cinaciguat (BAY 58-2667) in Healthy Male Volunteers
- (2008) Reiner Frey et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats
- (2008) Pál Pacher et al. Nature Protocols
- Osmotic polyuria: an overlooked mechanism in diabetic nephropathy
- (2008) S. Wang et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effects of Selective Phosphodiesterase-5-Inhibition on Myocardial Contractility and Reperfusion Injury After Heart Transplantation
- (2008) Sivakkanan Loganathan et al. TRANSPLANTATION
- Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus
- (2007) A Schäfer et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started